<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">101492916</journal-id>
<journal-id journal-id-type="pubmed-jr-id">35648</journal-id>
<journal-id journal-id-type="nlm-ta">Am J Intellect Dev Disabil</journal-id>
<journal-id journal-id-type="iso-abbrev">Am J Intellect Dev Disabil</journal-id>
<journal-title-group>
<journal-title>American journal on intellectual and developmental disabilities</journal-title>
</journal-title-group>
<issn pub-type="ppub">1944-7515</issn>
<issn pub-type="epub">1944-7558</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">28452584</article-id>
<article-id pub-id-type="pmc">5424621</article-id>
<article-id pub-id-type="doi">10.1352/1944-7558-122.3.247</article-id>
<article-id pub-id-type="manuscript">NIHMS855232</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Outcome Measures for Clinical Trials in Down Syndrome</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Esbensen</surname>
<given-names>Anna J.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Hooper</surname>
<given-names>Stephen R.</given-names>
</name>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Fidler</surname>
<given-names>Deborah</given-names>
</name>
<xref ref-type="aff" rid="A3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Hartley</surname>
<given-names>Sigan</given-names>
</name>
<xref ref-type="aff" rid="A4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Edgin</surname>
<given-names>Jamie</given-names>
</name>
<xref ref-type="aff" rid="A5">5</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>d’Ardhuy</surname>
<given-names>Xavier Liogier</given-names>
</name>
<xref ref-type="aff" rid="A6">6</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Capone</surname>
<given-names>George</given-names>
</name>
<xref ref-type="aff" rid="A7">7</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Conners</surname>
<given-names>Frances</given-names>
</name>
<xref ref-type="aff" rid="A8">8</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Mervis</surname>
<given-names>Carolyn B.</given-names>
</name>
<xref ref-type="aff" rid="A9">9</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Abbeduto</surname>
<given-names>Leonard</given-names>
</name>
<xref ref-type="aff" rid="A10">10</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Rafii</surname>
<given-names>Michael</given-names>
</name>
<xref ref-type="aff" rid="A11">11</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Krinsky-McHale</surname>
<given-names>Sharon J.</given-names>
</name>
<xref ref-type="aff" rid="A12">12</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Urv</surname>
<given-names>Tiina</given-names>
</name>
<xref ref-type="aff" rid="A13">13</xref>
</contrib>
<contrib contrib-type="author">
<collab>Outcome Measures Working Group</collab>
<xref ref-type="author-notes" rid="FN2">*</xref>
</contrib>
</contrib-group>
<aff id="A1"><label>1</label>Cincinnati Children’s Hospital Medical Center</aff>
<aff id="A2"><label>2</label>University of North Carolina</aff>
<aff id="A3"><label>3</label>Colorado State University</aff>
<aff id="A4"><label>4</label>University of Wisconsin – Madison</aff>
<aff id="A5"><label>5</label>University of Arizona</aff>
<aff id="A6"><label>6</label>Roche Innovation Center Basel</aff>
<aff id="A7"><label>7</label>Kennedy Krieger Institute</aff>
<aff id="A8"><label>8</label>University of Alabama</aff>
<aff id="A9"><label>9</label>University of Louisville</aff>
<aff id="A10"><label>10</label>MIND Institute, University of California, Davis School of Medicine</aff>
<aff id="A11"><label>11</label>University of California, San Diego</aff>
<aff id="A12"><label>12</label>New York State Institute for Basic Research in Developmental Disabilities</aff>
<aff id="A13"><label>13</label>Eunice Kennedy Shriver National Institute of Child Health and Human Development</aff>
<author-notes>
<corresp id="FN1">Correspondence concerning this article should be addressed to Anna J. Esbensen, Cincinnati Children’s Hospital Medical Center, Division of Developmental and Behavioral Pediatrics, MLC 4002, 3430 Burnet Avenue, Cincinnati, OH 45229. <email>anna.esbensen@cchmc.org</email></corresp>
<fn id="FN2">
<label>*</label>
<p>
<bold>Outcome Measures Working Group Participants</bold>
</p>
<p><bold>Cognition Working Group:</bold> Leonard Abbeduto, Frances Conners, Jamie Edgin, Michael Harpold, Stephen Hooper, Sharon J. Krinsky-McHale, Nancy Raitano Lee, Xavier Liogier d’Ardhuy, Carolyn Mervis, Roger Reeves, Michael Ropacki, Paul Wang</p>
<p><bold>Behavior Working Group:</bold> George Capone, Elisabeth Dykens, Anna Esbensen, Deborah Fidler, Sigan Hartley, Seth Keller, Michael Rafii, Sara Weir</p>
</fn>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>20</day>
<month>3</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="ppub">
<month>5</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>01</day>
<month>5</month>
<year>2018</year>
</pub-date>
<volume>122</volume>
<issue>3</issue>
<fpage>247</fpage>
<lpage>281</lpage>
<!--elocation-id from pubmed: 10.1352/1944-7558-122.3.247-->
<abstract>
<p id="P1">Increasingly individuals with intellectual and developmental disabilities, including Down syndrome, are being targeted for clinical trials. However, a challenge exists in effectively evaluating the outcomes of these new pharmacological interventions. Few empirically evaluated, psychometrically sound outcome measures appropriate for use in clinical trials with individuals with Down syndrome have been identified. To address this challenge, the NIH assembled leading clinicians and scientists to review existing measures and identify those that currently are appropriate for trials; those that may be appropriate after expansion of age range addition of easier items, and/or downward extension of psychometric norms; and areas where new measures need to be developed. This paper focuses on measures in the areas of cognition and behavior.</p>
</abstract>
<kwd-group>
<kwd>Down syndrome</kwd>
<kwd>intellectual disability</kwd>
<kwd>assessment</kwd>
<kwd>cognition</kwd>
<kwd>behavior</kwd>
<kwd>clinical trials</kwd>
</kwd-group>
</article-meta>
</front>
</article>
</pmc-articleset>